Explore the latest in atrial fibrillation, including advances in treatment and stroke prevention, recent guidelines, and long-term outcomes.
This case report describes a paroxysmal atrial fibrillation associated with an unroofed coronary sinus, a rare type of atrial septal defect.
This randomized trial compares the effect of transcatheter pulmonary vein isolation during catheter ablation with vs without ethanol infusion into the vein of Marshall, an embryologic remnant of the left superior vena cava implicated in atrial fibrillation pathogenesis, on freedom from atrial arrhythmia at 12 months.
This case report describes a person in their 70s found unconscious and unresponsive who had a history of hypertension, dyslipidemia, atrial fibrillation, seizure disorder, and coronary artery disease and an implantable loop recorder placed 6 months prior.
This secondary analysis of a randomized clinical trial assesses the subtype of recurrent ischemic stroke after embolic stroke of underdetermined source, the interaction with treatment assignment, and the consistency of cerebral location of the qualifying and recurrent strokes in the study population of the NAVIGATE-ESUS trial.
This cohort study investigates heart rate and cardiac troponin levels in patients admitted to the emergency department with symptomatic atrial fibrillation.
This case report describes a rare complication of radiofrequency ablation for atrial fibrillation, with a fatal outcome.
This cohort study assesses the association between annual, residential-level exposure to fine particulate matter and ischemic stroke in individuals with atrial fibrillation.
This Teachable Moment describes a man in his 80s with a history of paroxysmal atrial fibrillation and transient ischemic attack who presented following a mechanical fall.
This retrospective study compared the rate of ischemic stroke or transient ischemic attack among Olmstead County, Minnesota, residents with vs without new-onset postoperative atrial fibrillation after undergoing noncardiac surgery.
This randomized clinical trial assesses the use of a shared decision-making tool during clinical encounters and the effects on anticoagulant treatment decisions in patients with atrial fibrillation who are at risk of experiencing stroke.
This cohort study estimates atrial fibrillation (AF) incidence rates from 2006 to 2018 in a US community-based setting and investigates possible explanations for increasing AF by evaluating the changing features of incident AF cases and the pool of patients at risk for AF.
This population-based cohort study assesses the 30-day risk of hospital admission with hemorrhage after coprescription of clarithromycin compared with azithromycin among older adults taking a direct oral anticoagulant.
This secondary analysis of a randomized clinical trial evaluates the association of baseline atrial fibrillation episode duration with post–atrial fibrillation ablation arrhythmia outcomes.
This cohort study in Taiwan compares the clinical outcomes of warfarin use and non–vitamin K antagonist oral anticoagulant use in patients with atrial fibrillation with a history of intracranial hemorrhage using a nationwide cohort with atrial fibrillation.
This network meta-analysis identifies optimal antithrombotic regimens in terms of major bleeding and ischemic risk for patients with atrial fibrillation undergoing percutaneous coronary intervention by evaluating 5 randomized clinical trials.
This Viewpoint argues for the systematic identification of left atrium myopathy to guide tailored therapy in atrial fibrillation and heart failure with preserved ejection fraction.
This comparative effectiveness study evaluates drug-drug interactions between direct oral anticoagulants and verapamil or diltiazem in patients with no history of kidney disease.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: